Search

Your search keyword '"Burkholderia cenocepacia growth & development"' showing total 51 results

Search Constraints

Start Over You searched for: Descriptor "Burkholderia cenocepacia growth & development" Remove constraint Descriptor: "Burkholderia cenocepacia growth & development"
51 results on '"Burkholderia cenocepacia growth & development"'

Search Results

1. Interactions between Pseudomonas aeruginosa and six opportunistic pathogens cover a broad spectrum from mutualism to antagonism.

2. Glycoproteomic and proteomic analysis of Burkholderia cenocepacia reveals glycosylation events within FliF and MotB are dispensable for motility.

3. Identification of putative essential protein domains from high-density transposon insertion sequencing.

4. One gene, multiple ecological strategies: A biofilm regulator is a capacitor for sustainable diversity.

5. Characterization of Volatile Organic Compounds Emitted from Endophytic Burkholderia cenocepacia ETR-B22 by SPME-GC-MS and Their Inhibitory Activity against Various Plant Fungal Pathogens.

6. Negative frequency-dependent selection maintains coexisting genotypes during fluctuating selection.

7. PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection.

8. Loss of O -Linked Protein Glycosylation in Burkholderia cenocepacia Impairs Biofilm Formation and Siderophore Activity and Alters Transcriptional Regulators.

9. Small RNA NcS27 co-regulates utilization of carbon sources in Burkholderia cenocepacia J2315.

10. The Eno Gene of Burkholderia cenocepacia Strain 71-2 is Involved in Phosphate Solubilization.

11. Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms.

12. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).

13. Elucidation of the mechanism behind the potentiating activity of baicalin against Burkholderia cenocepacia biofilms.

14. Burkholderia cenocepacia integrates cis -2-dodecenoic acid and cyclic dimeric guanosine monophosphate signals to control virulence.

15. Identification of small RNAs abundant in Burkholderia cenocepacia biofilms reveal putative regulators with a potential role in carbon and iron metabolism.

16. The Essential Genome of Burkholderia cenocepacia H111.

17. Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions.

18. Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c-di-GMP effector BerB.

19. Cheating fosters species co-existence in well-mixed bacterial communities.

20. The LpxL acyltransferase is required for normal growth and penta-acylation of lipid A in Burkholderia cenocepacia.

21. Identification and analysis of genomic islands in Burkholderia cenocepacia AU 1054 with emphasis on pathogenicity islands.

22. Synthetic Cystic Fibrosis Sputum Medium Regulates Flagellar Biosynthesis through the flhF Gene in Burkholderia cenocepacia.

23. Biofilms produced by Burkholderia cenocepacia: influence of media and solid supports on composition of matrix exopolysaccharides.

24. Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient.

25. Quantification of type VI secretion system activity in macrophages infected with Burkholderia cenocepacia.

26. An electron transfer flavoprotein is essential for viability and its depletion causes a rod-to-sphere change in Burkholderia cenocepacia.

27. [The Effect of Introduction of the Heterologous Gene Encoding the N-acyl-homoserine Lactonase (aiiA) on the Properties of Burkholderia cenocepacia 370].

28. σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111.

29. A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia.

30. Characterization of a novel two-component system in Burkholderia cenocepacia.

31. Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine.

32. Pseudomonas aeruginosa displays an altered phenotype in vitro when grown in the presence of mannitol.

33. Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells.

34. The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid.

35. Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water.

36. Broad-spectrum anti-biofilm peptide that targets a cellular stress response.

37. A novel siderophore-independent strategy of iron uptake in the genus Burkholderia.

38. Efficacy of the biocide Steri-7 against the common Gram-negative bacterial pathogens (Burkholderia cenocepacia, Burkholderia gladioli, Burkholderia multivorans, Pseudomonas aeruginosa and Stenotrophomonas maltophilia) associated with cystic fibrosis (CF).

39. Centromere binding and evolution of chromosomal partition systems in the Burkholderiales.

40. [Mutants of Burkholderia cenocepacia with a change in synthesis of N-acyl-homoserine lactones--signal molecules of Quorum Sensing regulation].

41. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.

42. High confidence prediction of essential genes in Burkholderia cenocepacia.

43. The novel cis-encoded small RNA h2cR is a negative regulator of hfq2 in Burkholderia cenocepacia.

44. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.

45. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.

46. Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm.

47. Phenylalanine induces Burkholderia cenocepacia phenylacetic acid catabolism through degradation to phenylacetyl-CoA in synthetic cystic fibrosis sputum medium.

48. Burkholderia cenocepacia ShvR-regulated genes that influence colony morphology, biofilm formation, and virulence.

49. The dioxygenase-encoding olsD gene from Burkholderia cenocepacia causes the hydroxylation of the amide-linked fatty acyl moiety of ornithine-containing membrane lipids.

50. Differences in strategies to combat osmotic stress in Burkholderia cenocepacia elucidated by NMR-based metabolic profiling.

Catalog

Books, media, physical & digital resources